Title	Publication Date	Language	Citations
CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review	2020/10/21	English	25
The Misdiagnosis of CIDP: A Review	2020/03/26	English	25
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling	2022/04/25	English	25
Fingolimod Immune Effects Beyond Its Sequestration Ability	2019/11/06	English	24
Therapy of Sialorrhea with Botulinum Neurotoxin	2019/09/21	English	23
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer	2019/08/27	English	23
Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review	2017/07/28	English	23
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease	2021/08/23	English	23
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)	2018/04/09	English	23
Epilepsy: Knowledge, Attitude, and Practice Among Secondary School Teachers in Khartoum State	2017/10/23	English	22
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review	2022/03/23	English	22
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion	2019/03/15	English	22
The European LEMS Registry: Baseline Demographics and Treatment Approaches	2015/11/02	English	22
A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment	2018/07/09	English	22
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Pseudobulbar Affect	2014/06/01	English	22
Post Hoc Analysis of Nutritional Status in Patients with Transthyretin Familial Amyloid Polyneuropathy: Impact of Tafamidis	2014/12/01	English	22
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study	2022/06/02	English	22
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations	2022/09/03	English	21
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife	2020/04/30	English	21
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)	2015/10/27	English	21
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis	2016/10/15	English	21
Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier	2018/11/09	English	21
Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada	2016/05/30	English	21
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide	2016/02/10	English	21
Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary	2020/11/02	English	21
A Prospective Study of Patients with Brain MRI Showing Incidental T2 Hyperintensities Addressed as Multiple Sclerosis: a Lot of Work to do Before Treating	2014/12/01	English	21
Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice	2021/05/27	English	21
Acupuncture and Its Role in the Treatment of Migraine Headaches	2020/10/01	English	20
Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study	2013/03/13	English	20
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes	2019/01/31	English	20